当前位置:科学网首页 > 小柯机器人 >详情
Cofilin-1的N-同型半胱氨酸化通过破坏肌动蛋白动力学加重癫痫病理生理
作者:小柯机器人 发布时间:2026/7/3 13:06:45

2026年7月2日,同济大学梅馨予小组在《神经科学通报》杂志发表论文,宣布他们的研究认为Cofilin-1的N-同型半胱氨酸化通过破坏肌动蛋白动力学加重癫痫病理生理。

该研究团队发现N-同型半胱氨酸化Cofilin-1 (N-Hcy-CFL1)是Hcy水平升高与儿童癫痫之间的分子联系。该研究组在癫痫患者和高同型半胱氨酸血症的同母位模型中检测到N-Hcy-CFL1。质谱分析鉴定了CFL1中hcy依赖的赖氨酸修饰,功能分析,包括肌动蛋白解聚、F/G-肌动蛋白比率和轴突伸长,表明CFL1活性受损,随之而来的是细胞骨架刚性。这些变化表现为F-肌动蛋白水平升高,F/G-肌动蛋白比值升高,轴突生长异常。

在体内,高同型半胱氨酸血症小鼠表现出长时间的癫痫发作和轴突重塑,这两种症状都被CFL1定向干预所减轻。临床上,血液Hcy水平与患者脑组织中N-Hcy-CFL1水平相关,支持其作为生物标志物的潜力。总之,这些发现确定了N-Hcy-CFL1是一种致病介质,并表明N-同型半胱氨酸化是一种超越传统Hcy降低策略的治疗靶点。

研究人员表示,升高的同型半胱氨酸(Hcy)水平有助于儿童癫痫的发生和发展。然而,降低Hcy治疗提供有限的益处,提示其他致病机制。

附:英文原文

Title: N-Homocysteinylation of Cofilin-1 Aggravates Epileptic Pathophysiology via Disruption of Actin Dynamics

Author: Mei, Xinyu, Liu, Yi, Fang, Chuantao, Guo, Jingjing, Tan, Yanfeng, Shi, Ying, Xiao, Jianbo, Qi, Dashi

Issue&Volume: 2026-07-02

Abstract: Elevated homocysteine (Hcy) levels contribute to the onset and progression of childhood epilepsy. However, Hcy-lowering therapies provide limited benefits, suggesting additional pathogenic mechanisms. Here, we identified N-homocysteinylated Cofilin-1 (N-Hcy-CFL1) as a molecular link between elevated Hcy levels and childhood epilepsy. We detected N-Hcy-CFL1 in patients with epilepsy and in a mouse model of hyperhomocysteinemia. Mass spectrometry identified Hcy-dependent lysine modifications in CFL1, and functional assays, including actin depolymerization, the F/G-actin ratio, and axonal elongation, demonstrated impaired CFL1 activity and consequent cytoskeletal rigidity. These changes manifested as increased F-actin levels, increased F/G-actin ratio, and abnormal axonal growth. In vivo, hyperhomocysteinemic mice exhibited prolonged seizures and axonal remodeling, both of which were attenuated by CFL1-directed interventions. Clinically, blood Hcy levels correlated with N-Hcy-CFL1 levels in patients’ brain tissues, supporting its potential as a biomarker. Together, these findings identify N-Hcy-CFL1 as a pathogenic mediator and suggest that N-homocysteinylation is a therapeutic target beyond conventional Hcy-lowering strategies.

DOI: 10.1007/s12264-026-01652-z

Source: https://link.springer.com/article/10.1007/s12264-026-01652-z

期刊信息

Neuroscience Bulletin《神经科学通报》,创刊于2006年。隶属于施普林格·自然出版集团,最新IF:5.6

官方网址:https://link.springer.com/journal/12264
投稿链接:https://mc03.manuscriptcentral.com/nsb